Find innovation in the Product Theater
The Product Theater is the premiere venue for industry to hold non-CME educational programming regarding new products and services and the latest in data and research findings. Each 60-minute program at AUA2023 will take place inside the theater located within the Science & Technology Hall and The Square.
Friday, April 28
Product Theater in The Square12:30-1:30 p.m.
An Adaptable Approach: Is JELMYTO Appropriate Across Low-Grade UTUC Presentations and Practice Patterns?
Jennifer Linehan, MD; Sandip M. Prasad, MD, MPhil | Sponsored by: UroGen® Pharma
Product Theater in the Science & Technology Hall, Booth #1260
12-1 p.m.
Elevate Care in Advanced Prostate Cancer
David Morris, MD | Sponsored by: Astellas Pharma and Pfizer Oncology
2:30-3:30 p.m.
Radioligand Therapy: Open Clinical Trials in Prostate Cancer and Logistics of Administration
Dr. Jared Driskill, Pharm.D; Dr. Dao Le, Pharm.D | Sponsored by: Novartis
Saturday, April 29
Product Theater in The Square7-8 a.m.
A Treatment Option for Select Genitourinary Cancers and Adverse Reactions Management
Daniel J. Canter, MD | Sponsored by: Merck & Co., Inc.
12:30-1:30 p.m.
Incorporating Checkpoint Inhibition in the Treatment Landscape for Patients With Pathologically High-Risk Urothelial Carcinoma
Jayram Gautam | Sponsored by: Bristol Myers Squibb
Product Theater in the Science & Technology Hall, Booth #1260
9:30-10:30 a.m.
ERLEADA® (apalutamide)—For the Treatment of Patients With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Christopher M. Pieczonka, MD; Robert E. Reiter, MD; Aaron Berger, MD | Sponsored by: Janssen
12-1 p.m.
Exploring Clinical Evidence of a Treatment Option for Metastatic Castration-Sensitive Prostate Cancer
Kenneth Kernen | Sponsored by: Astellas Pharma and Pfizer Oncology
2:30-3:30 p.m.
Choices That Matter: Optimizing BPH Care for Urologists, APPs and Patients
Matt Ashley, MD, moderator; Janelle Bunce, PA-C; Claus Roehrborn, MD | Sponsored by: Teleflex Interventional Urology
Sunday, April 30
Product Theater in The Square12:30-1:30 p.m.
Case-Based Learnings on a Treatment Approach for Certain Patients With High-Risk NMIBC
Kenneth Kernen, MD | Sponsored by: Merck & Co., Inc.
Product Theater in the Science & Technology Hall, Booth #1260
9:30-10:30 a.m.
PSMA-PET in Prostate Cancer: A Case-Based Discussion
Phillip J. Koo, MD; Jason Efstathiou, MD, Dphil; Leonard Gomella, MD, FACS; Michael Gorin, MD; Oliver Sartor, MD | Sponsored by: Lantheus
12-1 p.m.
Discover the Impact of GEMTESA: A Selective β3-Adrenergic Agonist for Effective OAB Treatment
Nathaniel Barnes, MD; Ashley H. Tapscott, DO | Sponsored by: Urovant Sciences